Elanco's Credelio™ CAT (lotilaner) Receives First FDA Emergency Use Authorization (EUA) for Treatment of New World Screwworm (NWS) in Cats

Elanco Animal Health Incorporated (NYSE: ELAN) today announced it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for Credelio™ CAT (lotilaner) to treat ...

CBSE Class 11 Biology Deleted Syllabus 2025-26 - Check Here

Check the updated CBSE Class 11 2025-26 deleted syllabus: a complete list of topics removed or revised, subject-wise changes, ...

HCW Biologics Announces Initiation of First-In-Human Clinical Trial to Evaluate HCW9302 in an Autoimmune Disease

First Patient Dosed at The Ohio State UniversityWexner Medical Center in this Multi-Center TrialActive component of HCW9302 is interleukin-2 -- ...

Emulate Launches Brain-Chip R1 to Advance Neurological Drug Development, in Partnership with FUJIFILM Cellular Dynamics

Emulate, Organ-on-a-Chip pioneer, announces strategic product collaboration with FUJIFILM Cellular Dynamics to address CNS ...